All news

MRSH trades 20.9% below analyst target ahead of Q3

Alpha Vantage · AD HOC NEWS · · AI-summarised by FinFlash

Marsh & McLennan stock is facing a Q3 test following its acquisition of Accel Holdings, which expands its insurance and advisory capabilities in the Upper Midwest. The company will report third-quarter results on October 15, 2026, with analysts anticipating increased earnings per share and revenue. JPMorgan has maintained an Overweight rating and raised its price target for the stock.

Read original source

MRSH company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.